You are here: Industry Insights > NATCO

News List

Natco gets US FDA approval for Carfilzomib vials expresspharma
June 16, 2021
The parties have received final approval for 10 mg and 60 mg strengths of the product and tentative approval for 30 mg strength of the product.
Natco commences phase-III clinical trial of Molnupiravir for COVID-19 treatment expresspharma
May 24, 2021
Natco Pharma has initiated Phase-III clinical trial of Molnupiravir capsules in India. Its first patient was dosed at Yashoda Hospitals, Hyderabad.
Natco Pharma gets USFDA approval for lenalidomide capsules expresspharma
May 24, 2021
Natco Pharma has received final approval of its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules, 5 mg, 10 mg, 15 mg, and 25 mg strengths, from the US Food and Drug Administration (FDA), and tentative approval for the 2.5 mg and 20 mg ...
Lilly signs voluntary licensing agreement with Natco for baricitinib expresspharma
May 18, 2021
Lilly had also signed voluntary license agreements with Cipla, Lupin, Sun Pharma, Dr Reddy’s, MSN Labs and Torrent Pharma.
NATCO receives emergency-use approval for Baricitinib tablets for COVID-19 treatment expresspharma
May 07, 2021
Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19-positive patients.
NATCO applies to CDSCO for EUA of Molnupiravir capsules to treat COVID-19 expresspharma
April 27, 2021
Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2 replication.
NATCO gets tentative US FDA approval for Ibrutinib tablets expresspharma
April 12, 2021
NATCO feels that it is eligible for 180 days of sole generic marketing exclusivity for all the strengths of the tablet dosage form of the product at the time of launch.
NATCO ventures into Pheromone based tech for Integrated Pest Management expresspharma
March 16, 2021
Natco Pharma is pleased to announce its foray into pheromone-based mating disruption technology for integrated pest management (IPM) solution to farmers in India.
NATCO gets US FDA nod for Everolimus tablets expresspharma
March 09, 2021
They are indicated in the treatment of breast cancer and a few other types of cancers.
NATCO launches Brivaracetam tablets in India expresspharma
March 01, 2021
Natco Pharma announced the launch of Brivaracetam tablets under brand BRECITA in India.

Previous page 1 2 Next page